DiscoverThe NRG Oncology PodcastNRG-GU012, the SAMURAI Study, with Dr. William A. Hall
NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

Update: 2025-03-11
Share

Description

Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

NRG Oncology